DMAA stock news
This page provides real-time market news, earnings updates, and company announcements related to Drugs Made In America Acquisition Corp. (DMAA).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-16 09:33 EST
Polyrizon Ltd. Announces $3.5 Million Registered Direct Offering and Private Placement
Finviz2026-04-07 12:03:45
Jaguar Health Reports 2025 Financials
Finviz2026-04-07 12:33:46
AtaiBeckley's BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
Finviz2026-04-08 10:03:59
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Finviz2026-04-08 10:03:59
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
Finviz2026-04-08 12:03:53
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Finviz2026-04-08 12:33:11
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
Finviz2026-04-08 12:33:10
Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements
Finviz2026-04-08 20:18:40
Foundayo (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
Finviz2026-04-09 10:48:06
Labcorp Declares Quarterly Dividend
Finviz2026-04-09 10:57:43
Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol
Finviz2026-04-09 11:33:50
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL
Finviz2026-04-13 10:48:09
Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
Finviz2026-04-13 12:33:38
Children's Hospital of Philadelphia and Labcorp Announce a Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide
Finviz2026-04-13 12:33:39
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
Finviz2026-04-13 21:27:11
Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research
Finviz2026-04-14 11:03:55
Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board
Finviz2026-04-14 11:03:57
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
Finviz2026-04-14 12:06:46
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Finviz2026-04-14 12:06:47
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
Finviz2026-04-14 12:39:39
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation
Finviz2026-04-14 20:06:56
UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer
Finviz2026-04-08 12:03:53
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Finviz2026-04-08 12:33:11
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
Finviz2026-04-08 12:33:10
Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements
Finviz2026-04-08 20:18:40
Foundayo (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
Finviz2026-04-09 10:48:06
Labcorp Declares Quarterly Dividend
Finviz2026-04-09 10:57:43
Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol
Finviz2026-04-09 11:33:50
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL
Finviz2026-04-13 10:48:09
Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
Finviz2026-04-13 12:33:38
Children's Hospital of Philadelphia and Labcorp Announce a Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide
Finviz2026-04-13 12:33:39
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
Finviz2026-04-13 21:27:11
Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research
Finviz2026-04-14 11:03:55
Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board
Finviz2026-04-14 11:03:57
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
Finviz2026-04-14 12:06:46
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Finviz2026-04-14 12:06:47
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
Finviz2026-04-14 12:39:39
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation
Finviz2026-04-14 20:06:56
DMAA stock chart
DMAA stock detailsDMAA stock price change
On the last trading day, DMAA stock closed at 10.52 USD, with a price change of 0.05% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more